Nuwellis, Inc

Restoring Fluid Balance. Renewing Hope. Nuwellis (Nasdaq: NUWE) is a medical technology company dedicated to improving the lives of patients with fluid overload—a common and serious complication of heart failure, critical illness, and other complex conditions. Our Aquadex SmartFlow® system provides clinicians with a precise, safe, and flexible way to remove excess fluid, helping restore balance and support recovery. Designed for use in patients weighing 20 kg or more, Aquadex is used across hospital settings to improve outcomes when fluid management becomes a challenge. Headquartered in Eden Prairie, Minnesota, with a wholly owned subsidiary in Ireland, Nuwellis has been publicly traded on the Nasdaq Capital Market since 2012. We are a purpose-driven team focused on clinical impact, meaningful innovation, and supporting the care teams who make better outcomes possible. Learn more at nuwellis.com